These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1860104)
21. Insulin antibodies in non-insulin-dependent diabetes mellitus: effect of treatment with semisynthetic human insulin. Lauritano AA; Clements RS; Bell D Clin Ther; 1989; 11(2):268-77. PubMed ID: 2660998 [TBL] [Abstract][Full Text] [Related]
22. [Insulin therapy: an ongoing topic]. Waldhäusl W Wien Med Wochenschr; 1997; 147(9):199. PubMed ID: 9281231 [No Abstract] [Full Text] [Related]
23. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics. Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817 [TBL] [Abstract][Full Text] [Related]
25. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus. Mathieu C Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394 [TBL] [Abstract][Full Text] [Related]
26. Atherogenicity of insulin. Martin DB Diabetes Res Clin Pract; 1988; 4 Suppl 1():58-61. PubMed ID: 3042335 [No Abstract] [Full Text] [Related]
27. The impact of insulin upon atherosclerosis. Stout RW Horm Metab Res; 1994 Mar; 26(3):125-8. PubMed ID: 8005558 [No Abstract] [Full Text] [Related]
28. Cardiovascular safety of insulin: Between real-world data and reality. Mannucci E; Ferrannini E Diabetes Obes Metab; 2017 Sep; 19(9):1201-1204. PubMed ID: 28407342 [No Abstract] [Full Text] [Related]
29. Insulin resistance and atherosclerosis. Common roots for two common diseases? Taegtmeyer H Circulation; 1996 May; 93(10):1777-9. PubMed ID: 8635253 [No Abstract] [Full Text] [Related]
30. Guilt, or guilt by association? Insulin therapy in type 2 diabetes and death. Adler AI Lancet Diabetes Endocrinol; 2017 Jan; 5(1):7-8. PubMed ID: 27865757 [No Abstract] [Full Text] [Related]
31. Insulin: potential negative consequences of early routine use in patients with type 2 diabetes. Lebovitz HE Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S225-30. PubMed ID: 21525460 [No Abstract] [Full Text] [Related]
33. [Roles of adipocytokines in the development of atherosclerosis]. Yamauchi T Nihon Rinsho; 2007 Jul; 65 Suppl 7():63-70. PubMed ID: 17824015 [No Abstract] [Full Text] [Related]
34. Possible liver damage by biosynthetic human insulin. Shimizu H; Ohtani KI; Kudoh T; Tsuchiya T; Takahashi H; Sato N; Iriuchijima T; Mori M Diabetes Obes Metab; 1999 May; 1(3):179-80. PubMed ID: 11220297 [No Abstract] [Full Text] [Related]
35. Premature vascular degeneration in diabetes mellitus: pathogenesis, and relation to aging. SOLEZ C J Am Geriatr Soc; 1955 Oct; 3(10):804-10. PubMed ID: 13263098 [No Abstract] [Full Text] [Related]
36. --to: M. Koopmanschap: Coping with Type 2 diabetes: the patient's perspective. Diabetologia 45:S18-S22. Pouwer F; Adriaanse MC Diabetologia; 2003 Feb; 46(2):302-3. PubMed ID: 12627334 [No Abstract] [Full Text] [Related]